Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–130
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
≥ 18 years of age
Potassium ≥5.8 mmol/L
You may not be if
Possible pseudohyperkalaemia
Hyperkalaemia caused by any condition for which a therapy directed against the underlying cause of hyperkalaemia would be a better treatment option than treatment with insulin and glucose.
Dialysis session expected within 4h after randomization
Treated with any therapy intended to lower S-K between arriving at the hospital and randomization during Visit 1.
Clareo Health | A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8
